HOME >> BIOLOGY >> NEWS
Human Genome Sciences announces the discovery of a novel immune stimulant

Novel Protein Holds Potential to Enhance Body's Immune Response

Rockville, MD -- July 8, 1999 -- Human Genome Sciences, Inc. (NASDAQ: HGSI) announced today that it has discovered a novel immune stimulant that may have significant medical use for the treatment and prevention of infectious diseases, and may also contribute to the treatment of immune deficiency disorders. The discovery may also lead to new approaches to the treatment of certain types of leukemia and lymphoma. The immune stimulant, called B Lymphocyte Stimulator (BLyS), is a natural component of the immune system. The discovery and characterization of BLyS is described in the July 9, 1999 issue of Science magazine.

BLyS is a naturally occurring substance, a protein, made by the human body. It stimulates the production of high levels of antibodies by causing the antibody producing cells, called B cells, to grow and produce abundant antibodies. Antibodies act to protect the body from infections such as bacteria and viruses. People deficient for B cells are at high risk for infection.

BLyS may be a long sought missing link in the body's ability to protect itself from infection. For many years scientists have searched for substances that stimulate the growth of antibody producing cells. BLyS seems to be one of those substances. The discovery also helps to answer a well-known puzzle. It has been known that another type of immune cell, the monocyte, is involved in B cell stimulation and ultimately antibody production. The precise role of monocytes has been a mystery. The discovery that monocytes produce BLyS, a substance that stimulates B cell growth and activates antibody production, may be the answer to this long-standing riddle.

Potential Medical Uses of BLyS

The potential medical uses of BLyS may include:

    Treatment of Certain Immune Deficiency Syndromes
    Patients undergoing treatment for organ transplantation or patient
    '"/>


Contact: Kate de Santis
Kate_de_Santis@hgsi.com
301-251-6003
Human Genome Sciences, Inc.
9-Jul-1999


Page: 1 2 3 4

Related biology news :

1. Human chromosome 5 final sequence analysis released to public
2. Humans march to a faster genetic drummer than primates, UC Riverside research says
3. Applied Mathematical Models in Human Physiology
4. Human health risks in space flight focus of research internships
5. Human periodontal ligament stem cells isolated for the first time
6. Organization for Human Brain Mapping 2004 Annual Meeting
7. 20 May AAAS lecture: Computers that Respond to Human Emotion
8. Human brain works heavy statistics learning language
9. New Woods Hole Center for Oceans and Human Health established
10. European Society of Human Reproduction and Embryology conference - June 2004
11. Human genome-wide RNAi library for biotech and pharma research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/10/2020)... , ... July 09, 2020 , ... Today CJ BIO ... which will share insight on the “fifth taste” phenomenon that is revolutionizing ingredient mixes, ... Umami Advantage will be live on Monday, July 13, 2020 at11:00 AM (CDT) during ...
(Date:7/2/2020)... ... July 02, 2020 , ... ... (MBS) has announced a publication detailing the use of its revolutionary NEXTGENPCR ... chain reaction (RT-PCR) in 16 minutes. The article, titled "Ultra-fast one-step RT-PCR ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... announced that it has entered into a multi-year contract with Merus N.V., ... their translational and clinical research strategy to discover and develop ground-breaking drugs. ...
Breaking Biology News(10 mins):
(Date:9/1/2020)... ... September 01, 2020 , ... ... and diagnostics companies, has announced the placement of Julianne Averill , CPA, ... for leading all financial operations and implementing key business strategies to accelerate Alveo’s ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... engineering firm, is making available for free its new white paper – ... transport simulation testing into today’s biologics licensing application (BLA). In response, Modality ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... eSource has long been touted as the ... the history of eSource, the reasons it did not take off as quickly as ... source, the industry is moving towards capturing data electronically for clinical trials and then ...
Breaking Biology Technology:
Cached News: